Corona vs Blue Moon Which Offers More Value?

Corona and Blue Moon are two popular beer brands owned by Constellation Brands and Molson Coors respectively. While Corona is known for its light and refreshing taste, Blue Moon is recognized for its unique and artisanal flavors. Both stocks have seen fluctuations in their value over time, with Corona benefiting from its global popularity and Blue Moon often appealing to craft beer enthusiasts. Investors may consider factors such as market trends, brand recognition, and company performance when deciding between the two stocks.

Corona or Blue Moon?

When comparing Corona and Blue Moon, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Corona and Blue Moon.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Corona has a dividend yield of 2.91%, while Blue Moon has a dividend yield of 2.66%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Corona reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Blue Moon reports a 5-year dividend growth of 0.00% year and a payout ratio of -1374.41%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Corona P/E ratio at 19.58 and Blue Moon's P/E ratio at -225.86. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Corona P/B ratio is 0.37 while Blue Moon's P/B ratio is 2.22.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Corona has seen a 5-year revenue growth of -0.01%, while Blue Moon's is 0.12%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Corona's ROE at 1.91% and Blue Moon's ROE at -0.92%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are ¥961.00 for Corona and HK$3.76 for Blue Moon. Over the past year, Corona's prices ranged from ¥856.00 to ¥1001.00, with a yearly change of 16.94%. Blue Moon's prices fluctuated between HK$1.68 and HK$4.44, with a yearly change of 164.29%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.